DAFNA Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-74,953
| Closed | -$980K | – | 86 |
|
|
2022
Q3 | $980K | Sell |
74,953
-32,700
| -30% | -$428K | 0.26% | 55 |
|
|
2022
Q2 | $1.38M | Hold |
107,653
| – | – | 0.38% | 55 |
|
|
2022
Q1 | $1.64M | Buy |
107,653
+27,168
| +34% | +$414K | 0.43% | 58 |
|
|
2021
Q4 | $1.43M | Buy |
80,485
+15,000
| +23% | +$266K | 0.36% | 56 |
|
|
2021
Q3 | $1.38M | Buy |
65,485
+34,983
| +115% | +$735K | 0.37% | 60 |
|
|
2021
Q2 | $601K | Buy |
30,502
+20,502
| +205% | +$404K | 0.13% | 80 |
|
|
2021
Q1 | $291K | Buy |
+10,000
| New | +$291K | 0.07% | 85 |
|
|
2019
Q3 | – | Sell |
-6,265
| Closed | -$92K | – | 95 |
|
|
2019
Q2 | $92K | Buy |
+6,265
| New | +$92K | 0.03% | 83 |
|